Shorter radiation for early-stage glottic cancer
Part of Cancer, Ear, nose & throat clinical trials.
This study tests a shorter, higher-dose radiation schedule for people with early glottic cancer. It might mean fewer trips to the hospital and less burden on your voice box.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with squamous cell carcinoma of the glottis (a specific type of early vocal cord cancer).
- Your cancer must be at an early stage (T1 or T2) with no spread to nearby lymph nodes or distant organs.
- You must be at least 18 years old.
- You must be in relatively good health (able to do daily activities with some help if needed).
- You must not have had prior radiation or surgery to your voice box (except for a biopsy).
- You need to be able to attend follow-up visits and complete voice tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a shorter course of radiation (hypofractionated) works as well as the standard longer course for people with early-stage cancer of the vocal cords. The goal is to find a treatment that is more convenient and has similar results.
This trial studies whether adding radiation therapy after surgery can help people with early-stage voice box cancer that has poor differentiation (cells look very abnormal). It aims to improve outcomes for this specific type of cancer.
This study compares two ways to treat early supraglottic squamous-cell throat cancer: radiation therapy versus removing lymph node areas in the neck (neck dissection). It may help find which approach controls cancer while affecting quality of life as much as possible.
This study tries to see if less intense radiation can still work well for certain throat cancers linked to HPV. It is looking for people with early stage HPV-positive oropharynx cancer who may benefit from a lighter treatment plan.
This trial tests a shorter course of radiation for people with intermediate-risk head and neck cancer after surgery. It aims to reduce side effects while keeping treatment effective.
This study looks at whether adding radiation therapy after surgery improves outcomes for people with early-stage glottic cancer that involves the anterior commissure (the front part of the vocal cords). If you join, you may receive radiation therapy or not, and the researchers will compare the results.
Hear when a new Early Glottic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.